<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Eckhardt J</dc:creator>
  <dc:creator>Bachmann C</dc:creator>
  <dc:creator>Benucci S</dc:creator>
  <dc:creator>Elbaz M</dc:creator>
  <dc:creator>Ruiz A</dc:creator>
  <dc:creator>Zorzato F</dc:creator>
  <dc:creator>Treves S</dc:creator>
  <dc:date>2020</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Mutations in the RYR1 gene are the most common cause of human congenital myopathies, and patients with recessive mutations are severely affected and often display ptosis and/or ophthalmoplegia. In order to gain insight into the mechanism leading to extraocular muscle (EOM) involvement, we investigated the biochemical, structural and physiological properties of eye muscles from mouse models we created knocked-in for Ryr1 mutations. Ex vivo force production in EOMs from compound heterozygous RyR1p.Q1970fsX16+p.A4329D mutant mice was significantly reduced compared with that observed in wild-type, single heterozygous mutant carriers or homozygous RyR1p.A4329D mice. The decrease in muscle force was also accompanied by approximately a 40% reduction in RyR1 protein content, a decrease in electrically evoked calcium transients, disorganization of the muscle ultrastructure and a decrease in the number of calcium release units. Unexpectedly, the superfast and ocular-muscle-specific myosin heavy chain-EO isoform was almost undetectable in RyR1p.Q1970fsX16+p.A4329D mutant mice. The results of this study show for the first time that the EOM phenotype caused by the RyR1p.Q1970fsX16+p.A4329D compound heterozygous Ryr1 mutations is complex and due to a combination of modifications including a direct effect on the macromolecular complex involved in calcium release and indirect effects on the expression of myosin heavy chain isoforms.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/92785</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1093/hmg/ddaa056</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/32242214</dc:relation>
  <dc:source>Human molecular genetics. - 2020</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Genetics(clinical)</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Genetics</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Molecular Biology</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">General Medicine</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">Molecular basis of impaired extraocular muscle function in a mouse model of congenital myopathy due to compound heterozygous Ryr1 mutations.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
